Recent News

• 10.09.2025 - ESSA Announces Completion of Arrangement with XenoTherapeutics
• 10.06.2025 - ESSA Securityholders Approve Acquisition by XenoTherapeutics
• 09.30.2025 - ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order
• 09.24.2025 - ESSA Pharma Inc. Amends Agreement with XenoTherapeutics

Recent Filings

• 10.09.2025 - 8-K Current report
• 10.09.2025 - 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
• 10.09.2025 - EX-99.1 EX-99.1
• 10.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 10.06.2025 - 8-K Current report
• 10.06.2025 - EX-99.1 EX-99.1
• 10.03.2025 - 8-K Current report
• 10.03.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 09.30.2025 - EX-99.1 EX-99.1
• 09.30.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material